These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6754845)

  • 1. Pre-exposure prophylaxis with immune serum globulin for prevention of viral hepatitis in army recruits.
    Kark JD
    J Epidemiol Community Health; 1982 Sep; 36(3):176-82. PubMed ID: 6754845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three-year incidence of non-B viral hepatitis morbidity in a controlled trial of pre-exposure immune serum globulin prophylaxis.
    Kark JD; Witztum E; Mazkin H; Nili E; Danon YL
    Infection; 1984; 12(4):251-5. PubMed ID: 6386693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis of viral hepatitis with immune serum globulin in an endemic area. A trial in field units of the Israel Defence Forces.
    Kark JD
    Scand J Infect Dis; 1983; 15(1):3-6. PubMed ID: 6405480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.
    Kark JD; Bar-Shany S; Shor S; Merlinski L; Nili E
    J Epidemiol Community Health; 1985 Jun; 39(2):117-22. PubMed ID: 3891900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A antibody in Israel Defence Forces recruits.
    Kark JD; Bar-Shani S
    J Med Virol; 1981; 6(4):341-5. PubMed ID: 6264023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty years of experience with infectious hepatitis prevention in the Israel Defence Forces.
    Heering SL; Shohat T; Lerman Y
    Mil Med; 1992 Oct; 157(10):530-2. PubMed ID: 1454175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel.
    Green MS; Block C
    J Epidemiol Community Health; 1989 Jun; 43(2):187-90. PubMed ID: 2592909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trends in epidemiology of hepatitis in the Israel Defense Forces-- direction over several years].
    Gdalevich M; Gillis D; Mimouni D; Grotto I; Shpilberg O
    Harefuah; 2000 May; 138(9):755-7, 806, 805. PubMed ID: 10883230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute non-B hepatitis in the Israel Defence Forces: comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis.
    Matzkin H
    Hepatology; 1987; 7(6):1330-2. PubMed ID: 3119454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of fragmented IgG: two studies of postexposure prophylaxis in type A hepatitis.
    Brachott D; Lifschitz I; Mosley JW; Kendrick MA; Sgouris JT
    J Lab Clin Med; 1975 Feb; 85(2):281-6. PubMed ID: 122995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and subclinical hepatitis A occurring after immunoglobulin prophylaxis among Swedish UN soldiers in Sinai.
    Weiland O; Niklasson B; Berg R; Lundbergh P; Tideström L
    Scand J Gastroenterol; 1981; 16(8):967-72. PubMed ID: 7336137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.
    Victor JC; Monto AS; Surdina TY; Suleimenova SZ; Vaughan G; Nainan OV; Favorov MO; Margolis HS; Bell BP
    N Engl J Med; 2007 Oct; 357(17):1685-94. PubMed ID: 17947390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prevention of an epidemic of viral hepatitis A in the Czech army 1970-1989].
    Prymula R; Beran J; Splino M
    Epidemiol Mikrobiol Imunol; 1994 May; 43(2):67-70. PubMed ID: 8019813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of hepatitis A with immune globulin.
    Braithwaite MG
    J R Army Med Corps; 1983 Jun; 129(2):88-92. PubMed ID: 6620245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A: a case study.
    Egoz N
    Isr J Med Sci; 1986; 22(3-4):277-82. PubMed ID: 3091532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
    Thompson C; Dey A; Fearnley E; Polkinghorne B; Beard F
    Vaccine; 2017 Jan; 35(1):170-176. PubMed ID: 27876203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
    Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin prophylaxis for viral hepatitis.
    Feng CS
    J Fam Pract; 1982 Apr; 14(4):677-81. PubMed ID: 6802930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.